Literature DB >> 33488212

Synthesis and bioactivities of 1-(4-hydroxyphenyl)-2-((heteroaryl)thio)ethanones as carbonic anhydrase I, II and acetylcholinesterase inhibitors.

Cem Yamali1, Halise İnci GÜl1, Yeliz Demİr2, Cavit Kazaz3, İlhami GÜlÇİn3.   

Abstract

The discovery of enzyme targeting inhibitors is a popular area of drug research. Biological activities of the compounds bearing phenol and heteroaryl groups make them popular groups in drug design targeting important enzymes such as acetylcholinesterase (AChE, E.C.3.1.1.7) and carbonic anhydrases (CAs, EC 4.2.1.1). 1-(4-hydroxyphenyl)- 2-((aryl)thio)ethanones as possible AChE and CAs inhibitors were synthesized, and their chemical structures were confirmed by IR, 1H NMR, 13C NMR, and HRMS. The compounds 2 and 4 were found potent AChE inhibitors with the Ki values of 22.13 ±1.96 nM and 23.71 ±2.95 nM, respectively, while the compounds 2 (Ki = 8.61 ±0.90 nM, on hCA I) and 1 (Ki = 8.76 ±0.84 nM, on hCA II) had considerable CAs inhibitory potency. The lead compounds may help the scientists for the rational designing of an innovative class of drug candidates targeting enzyme-based diseases.
Copyright © 2020 The Author(s).

Entities:  

Keywords:  Carbonic anhydrases; acetylcholinesterase; heterocyclic; phenol

Year:  2020        PMID: 33488212      PMCID: PMC7751916          DOI: 10.3906/kim-2004-36

Source DB:  PubMed          Journal:  Turk J Chem        ISSN: 1300-0527            Impact factor:   1.239


  36 in total

Review 1.  Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?

Authors:  Vincenzo Alterio; Anna Di Fiore; Katia D'Ambrosio; Claudiu T Supuran; Giuseppina De Simone
Journal:  Chem Rev       Date:  2012-05-18       Impact factor: 60.622

2.  Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV.

Authors:  Alessio Innocenti; Ilhami Gülçin; Andrea Scozzafava; Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2010-07-13       Impact factor: 2.823

3.  Esterase activities of human carbonic anhydrases B and C.

Authors:  J A Verpoorte; S Mehta; J T Edsall
Journal:  J Biol Chem       Date:  1967-09-25       Impact factor: 5.157

4.  In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.

Authors:  Sevim Beyza Oztürk Sarikaya; Fevzi Topal; Murat Sentürk; Ilhami Gülçin; Claudiu T Supuran
Journal:  Bioorg Med Chem Lett       Date:  2011-05-25       Impact factor: 2.823

5.  N-Acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II.

Authors:  Alper Yıldırım; Ufuk Atmaca; Ali Keskin; Meryem Topal; Murat Çelik; İlhami Gülçin; Claudiu T Supuran
Journal:  Bioorg Med Chem       Date:  2015-03-20       Impact factor: 3.641

6.  Carbonic anhydrase inhibitors. Inhibition of human erythrocyte isozymes I and II with a series of antioxidant phenols.

Authors:  Murat Sentürk; Ilhami Gülçin; Arif Daştan; O Irfan Küfrevioğlu; Claudiu T Supuran
Journal:  Bioorg Med Chem       Date:  2009-02-04       Impact factor: 3.641

7.  Acetylcholinesterase and carbonic anhydrase inhibitory properties of novel urea and sulfamide derivatives incorporating dopaminergic 2-aminotetralin scaffolds.

Authors:  Bünyamin Özgeriş; Süleyman Göksu; Leyla Polat Köse; İlhami Gülçin; Ramin Ekhteiari Salmas; Serdar Durdagi; Ferhan Tümer; Claudiu T Supuran
Journal:  Bioorg Med Chem       Date:  2016-04-02       Impact factor: 3.641

8.  Multitarget Approach to Drug Candidates against Alzheimer's Disease Related to AChE, SERT, BACE1 and GSK3β Protein Targets.

Authors:  Larisa Ivanova; Mati Karelson; Dimitar A Dobchev
Journal:  Molecules       Date:  2020-04-17       Impact factor: 4.411

9.  Capsaicin: a potent inhibitor of carbonic anhydrase isoenzymes.

Authors:  Betul Arabaci; Ilhami Gulcin; Saleh Alwasel
Journal:  Molecules       Date:  2014-07-10       Impact factor: 4.411

10.  Design, Synthesis, and In Vitro Evaluation of Hydroxybenzimidazole-Donepezil Analogues as Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease.

Authors:  Sílvia Chaves; Simonetta Resta; Federica Rinaldo; Marina Costa; Romane Josselin; Karolina Gwizdala; Luca Piemontese; Vito Capriati; A Raquel Pereira-Santos; Sandra M Cardoso; M Amélia Santos
Journal:  Molecules       Date:  2020-02-22       Impact factor: 4.411

View more
  3 in total

1.  New Pd(II) complexes of the bisthiocarbohydrazones derived from isatin and disubstituted salicylaldehydes: Synthesis, characterization, crystal structures and inhibitory properties against some metabolic enzymes.

Authors:  Yeliz Kaya; Ayşe Erçağ; Yunus Zorlu; Yeliz Demir; İlhami Gülçin
Journal:  J Biol Inorg Chem       Date:  2022-02-17       Impact factor: 3.358

2.  Cytotoxic effect, enzyme inhibition, and in silico studies of some novel N-substituted sulfonyl amides incorporating 1,3,4-oxadiazol structural motif.

Authors:  Özcan Güleç; Cüneyt Türkeş; Mustafa Arslan; Yeliz Demir; Yeşim Yeni; Ahmet Hacımüftüoğlu; Ergün Ereminsoy; Ömer İrfan Küfrevioğlu; Şükrü Beydemir
Journal:  Mol Divers       Date:  2022-04-09       Impact factor: 3.364

3.  The palladium-based complexes bearing 1,3-dibenzylbenzimidazolium with morpholine, triphenylphosphine, and pyridine derivate ligands: synthesis, characterization, structure and enzyme inhibitions.

Authors:  Aydın Aktaş; Gül Yakalı; Yeliz Demir; İlhami Gülçin; Muhittin Aygün; Yetkin Gök
Journal:  Heliyon       Date:  2022-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.